Internal Server Error

List of Kite Pharma's Acquisitions

lockFilter this list
Kite Pharma has made a total of 4 acquisitions. These 4 acquisitions span 5 sectors: Immunotherapy, Oncology, Cell Therapy, Biotechnology, and Gene Therapy, across United States and Netherlands. Acquisition activity peaked in 2025, 2022, and 2018, with 1 acquisition each year. The average number of acquisitions per year for the 2020–2025 period is 0.4, and 0 acquisitions have been completed in the current calendar year. In August 2025, the company acquired Interius Biotherapeutics, a Philadelphia-based developer of gene therapies founded in 2020.

Here's the year on year acquisition history of Kite Pharma:

Year on year acquisition history of Kite Pharma2025202220182017Acquisitions Round Date (Yearly)012
  • Number of Total Acquisitions
Year
# Acquisitions
2025
1
2022
1
2018
1
2017
1

Recent acquisitions by Kite Pharma

Kite Pharma's most recent acquisition - Interius Biotherapeutics is a Developer of gene therapies for treating multiple diseases, founded in 2020 and located in Philadelphia. Kite Pharma acquired it in August 2025 for a price of $*****.

Here is the list of all acquisitions by Kite Pharma sorted by the latest acquisition date:

Acquired on
Acquired Company
Acquisition Price
Facilitators
Stake Acquired
Acquisition Multiple
Aug 21, 2025
fhuy
ughn
34
404
Dec 20, 2022
dmie
zqif
10
788
Jul 19, 2018
gqrt
q{ff
97
376

View the full list of acquisitions

Sign Up for Free

News related to Kite Pharma's acquisitions

lockFilter this list

Media has covered Kite Pharma for a total of 9 events in the last 1 year, 3 of them have been about acquisition activity.

View More Kite Pharma Recent News

FAQs about Acquisitions by Kite Pharma

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford